(NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company focused on advancing precision nerve-targeted treatments, today highlighted positive preliminary results from the first five ...
And take the prescribed medication, of course. But little else need be taught them to do ... The individual given this diagnosis isn’t told about the consequences of diabetes to the feet, especially ...